Kennametal Named Among America’s Best Midsize Companies by TIME
Kennametal Inc. (NYSE: KMT) has been honored with a spot on TIME’s list of America’s Best Midsize Companies 2025, a distinction that underscores the company’s leadership in areas such as employee satisfaction and sustainability transparency. This accolade, presented by TIME and Statista Inc., highlights Kennametal’s dedication to sustainable growth, an engaged workforce, and long-term value creation for stakeholders.
Sanjay Chowbey, President and CEO of Kennametal, expressed pride in the recognition, attributing it to the team’s dedication and the company’s focus on maintaining a values-driven culture. This latest achievement follows Kennametal’s inclusion on TIME’s World’s Best Companies 2024 list, further cementing its reputation for strong performance and a commitment to excellence.
With a history spanning over 85 years, Kennametal Inc. has established itself as a leader in industrial technology, offering materials science, tooling, and wear-resistant solutions to a global clientele. Serving industries such as aerospace and defense, earthworks, energy, general engineering, and transportation, Kennametal supports customers in nearly 100 countries, helping them achieve precision and efficiency in manufacturing. The company’s recent recognition by TIME serves as a testament to its ongoing efforts to innovate and lead in the industrial sector.
This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp
. The source URL for this press release is Kennametal Named Among America’s Best Midsize Companies by TIME.
More From Montreal Breaking
HR Excellence Linked to Business Success, HRO Today’s...
The HR100 ranking by HRO Today has unveiled a significant link between human resources excellence...
HOPE Hydration Secures $20M Series A Funding to...
HOPE Hydration, a tech-enabled company dedicated to providing free, filtered water through its digitally connected...
ABVC BioPharma Achieves $846K in Licensing Revenue Through...
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, has announced the receipt of a $150,000 cash...
Calidi Biotherapeutics Inc. Featured in NetworkNewsWire Spotlight on...
Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotech company, has been featured in a...